Morgan Stanley Maintains Overweight on Cardinal Health, Raises Price Target to $286

Benzinga · 3d ago
Morgan Stanley analyst Erin Wright maintains Cardinal Health (NYSE:CAH) with a Overweight and raises the price target from $265 to $286.